SCHEMBL7519196

SCHEMBL7519196

CCOC(=O)C(=CN(C)C)C(=O)c1cc(F)c(F)c(C)c1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.40
KMT2A Q03164 5/20 0.40
NPSR1 Q6W5P4 4/20 0.40
MAPT P10636 4/20 0.40
CYP2C9 P11712 2/20 0.40
LMNA P02545 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C19 P33261 1/20 0.40
CYP11B1 P15538 6/20 0.35
CYP11B2 P19099 5/20 0.35
GLO1 Q04760 1/20 0.34
S1PR4 O95977 1/20 0.34
S1PR1 P21453 1/20 0.34
MAPK1 P28482 1/20 0.34
USP2 O75604 1/20 0.34
IDE P14735 1/20 0.34
TNNI3 P19429 1/20 0.34
TNNT2 P45379 1/20 0.34
TNNC1 P63316 1/20 0.34
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7519192 1.00 MEN1 (0.40) MEN1KMT2ANPSR1MAPTCYP2C9
SCHEMBL30843044 0.91 MEN1 (0.40) MEN1KMT2ANPSR1MAPTCYP2C9
SCHEMBL9561731 0.91 MEN1 (0.40) MEN1KMT2ANPSR1MAPTCYP2C9
SCHEMBL3695378 0.91 MEN1 (0.40) MEN1KMT2ANPSR1MAPTCYP2C9
SCHEMBL4567521 0.91 MEN1 (0.40) MEN1KMT2ANPSR1MAPTCYP2C9
SCHEMBL9562415 0.90 CYP2C9 (0.40) MEN1KMT2ANPSR1MAPTCYP2C9
SCHEMBL9212344 0.90 CYP2C9 (0.40) MEN1KMT2ANPSR1MAPTCYP2C9
SCHEMBL2670497 0.89 MEN1 (0.37) MEN1KMT2ANPSR1MAPTCYP2C9
SCHEMBL2670499 0.89 MEN1 (0.37) MEN1KMT2ANPSR1MAPTCYP2C9
SCHEMBL4887112 0.87 CES2 (0.49) MEN1KMT2ANPSR1MAPTCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020193591-A1 Process for producing 5-amino-8-alkylquinolonecarboxylic acid derivative and intermediates in the production thereof DAIICHI PHARMACEUTICAL CO., LTD. 2002-12-19 US disclosed
EP-1167344-A1 PROCESS FOR PRODUCING 5-AMINO-8- ALKYLQUINOLO NECARBOXYLIC ACID DERIVATIVES AND INTERMEDIATES IN THE PRODUCTION THEREOF DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2002-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020193591-A1 Process for producing 5-amino-8-alkylquinolonecarboxylic acid derivative and intermediates in the production thereof SQOR, XDH, SPOUT1 MEN1 4664/4885KMT2A 2225/4885NPSR1 3011/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.